Clinical trial
Comparison of Insulins Aspart and Lispro in Insulin Pumps
NCT00461331 · Tulane University Health Sciences Center, Other · Completed
Key facts
| NCT number | NCT00461331 |
|---|---|
| Title | Comparison of Insulins Aspart and Lispro in Insulin Pumps |
| Official title | A Comparison of the Efficacy Beyond 48 Hours of Insulin Aspart (Novolog) and Lispro (Humalog) in Insulin Pumps |
| Lead sponsor | Tulane University Health Sciences Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin Aspart, Insulin Lispro |
| Enrollment | 20 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | Jan 8, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: